UMIN-CTR Clinical Trial

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Recruitment status Completed
Unique ID issued by UMIN UMIN000007959
Receipt No. R000009369
Scientific Title Pilot study to prevent a thin endometrium in patients undergoing clomiphene citrate treatment
Date of disclosure of the study information 2012/05/15
Last modified on 2018/12/04

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Pilot study to prevent a thin endometrium in patients undergoing clomiphene citrate treatment
Acronym prevent a thin endometrium
Scientific Title Pilot study to prevent a thin endometrium in patients undergoing clomiphene citrate treatment
Scientific Title:Acronym prevent a thin endometrium
Region
Japan

Condition
Condition Infertility
Classification by specialty
Endocrinology and Metabolism Obsterics and gynecology
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 To prevent a thin endometrium in patients undergoing clomiphene citrate treatment
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Endometrial thickness at the induction of ovulation was assessed by ultrasonography.
Key secondary outcomes

Base
Study type Interventional

Study design
Basic design Parallel
Randomization Randomized
Randomization unit Individual
Blinding Single blind -participants are blinded
Control No treatment
Stratification
Dynamic allocation YES
Institution consideration Institution is not considered as adjustment factor.
Blocking NO
Concealment Numbered container method

Intervention
No. of arms 3
Purpose of intervention Treatment
Type of intervention
Medicine
Interventions/Control_1 patients who were given 50mg/day clomiphene citrate on days 5-9(standard treatment, control group)
Interventions/Control_2 patients who were given 25mg/day clomiphene citrate on days 5-9(half-dose group)
Interventions/Control_3 patients who were given 50mg/day clomiphene citrate on days 1-5(early administration group)
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit
42 years-old >=
Gender Female
Key inclusion criteria Patients who diagnosed as having a thin endometrium(<8mm) during the standard clomiphene citrate treatment cycle were recruited in this study
Key exclusion criteria Patients were excluded if they had myoma, adenomyosis, congenital uterine anomaly, or ovarian tumors.
Patients were also excluded if they used estrogens, progesterone, androgens, or had chronic use of any medication, including nonsteroidial anti-inflammatory agents.
Target sample size 61

Research contact person
Name of lead principal investigator
1st name
Middle name
Last name akihisa takasaki
Organization Saiseikai Shimonoseki General Hospital
Division name Department of Obstetrics and Gynecology
Zip code
Address Yasuokacho 8-5-1, Shimonoseki, 759-6603 Japan
TEL 0832622300
Email a-takasaki@simo.saiseikai.or.jp

Public contact
Name of contact person
1st name
Middle name
Last name akihisa takasaki
Organization Saiseikai Shimonoseki General Hospital
Division name Department of Obstetrics and Gynecology
Zip code
Address Yasuokacho 8-5-1, Shimonoseki, 759-6603 Japan
TEL 0832622300
Homepage URL
Email a-takasaki@simo.saiseikai.or.jp

Sponsor
Institute Saiseikai Shimonoseki General Hospital
Institute
Department

Funding Source
Organization Saiseikai Shimonoseki General Hospital
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization
Address
Tel
Email

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2012 Year 05 Month 15 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Completed
Date of protocol fixation
2012 Year 05 Month 15 Day
Date of IRB
Anticipated trial start date
2012 Year 06 Month 01 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information

Management information
Registered date
2012 Year 05 Month 15 Day
Last modified on
2018 Year 12 Month 04 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000009369

Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name


Contact us.